Crizotinib for ROS1‐rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation

Crizotinib for ROS1‐rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation

Abstract Pulmonary tumor thrombotic microangiopathy (PTTM) is a rapidly progressive subtype of pulmonary hypertension (PH) associated with impaired right ventricular adaptation and very poor prognosis in cancer, and its rapid progression makes antemortem diagnosis and treatment extremely difficult....

Full description

Bibliographic Details
Main Authors: Daisetsu Aoyama, Shigefumi Fukui, Haruhiko Hirata, Keiko Ohta‐Ogo, Hideo Matama, Emi Tateishi, Tatsuya Nishii, Yasuhide Asaumi, Mamoru Toyofuku, Tatsuyoshi Ikeue, Takeshi Ogo, Hatsue Ishibashi‐Ueda, Satoshi Yasuda
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Pulmonary Circulation
Subjects:
crizotinib
lung cancer
pulmonary hypertension
pulmonary tumor thrombotic microangiopathy
venoarterial extracorporeal membrane oxygenation
Online Access:https://doi.org/10.1002/pul2.12047

Internet

https://doi.org/10.1002/pul2.12047

Similar Items